Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...

KoçDigital joined government and industry leaders at the official launch of the Advanced Manufacturing and Production Center (AMPC), a flagship project supporting Saudi Arabia’s Vision 2030 ...

Riyadh, Saudi Arabia – KoçDigital joined government and industry leaders at the official launch of the Advanced Manufacturing and Production Center (AMPC), a flagship project supporting Saudi Arabia’s ...

U.S. Commercial Launch of ORLYNVAHTM by Q4 2025; First Oral Penem Available in the U.S. Management to host a conference call at 4:30 p.m. ET today DUBLIN and CHICAGO, June 11, 2025 (GLOBE NEWSWIRE) -- ...

AMPC, or anonymized multi-party computation, has launched. It is the open source quantum secure multi-party computation (SMPC) setup from World that “anonymizes and securely protects the iris ...

In our study about 16.4% of the ceftazidime-resistant isolates were noted to produce AmpC-β-lactamases. However, in a similar study from India, AmpC production was observed in 55.5% of the ceftazidime ...

He went on to explain why ceftriaxone is not advisable for these infections, as it can induce AmpC production, rendering the drug ineffective. However, cefepime can be an option for strains with lower ...

Methods and analysis PeterPen is a multicentre, investigator-initiated, open-label, randomised controlled non-inferiority trial, comparing piperacillin–tazobactam with meropenem for third-generation ...

INTRODUCTION. Enterobacteria are often associated with drug resistance and contamination of fish and shrimp 1.Food contamination with multidrug-resistant bacteria, particularly extended-spectrum ...

Socioeconomic disparities may predict the prevalence of select antimicrobial resistant (AMR) organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA) and AmpC β-lactamase producers, ...